David Goeddel (1986)
David Goeddel talks about how another group was trying to make insulin.
David Goeddel was one of the first scientists Herb Boyer hired for the insulin project. Here, David Goeddel talks about Genentech's general strategy for synthesizing insulin.
David Goeddel talks about recombinant DNA.
David Goeddel talks about the other groups working on the insulin problem.
David Goeddel talks about what it was like to work at Genetech during its early days.
David Goeddel talks about the strategy Genentech used in making synthetic insulin.
In 1980, Genentech became the first publicly traded biotech company. David Goeddel talks about his investment.
Walter Gilbert's group tried to isolate the human insulin DNA sequence using the rat insulin DNA sequence.
Synthetic human insulin was the first golden molecule of the biotech industry and the direct result of recombinant DNA technology. Currently, millions of diabetics worldwide use synthetic insulin to regulate their blood sugar levels. Synthetic insulin i
Walter Gilbert talks about his group's early success with isolating the rat insulin gene and making recombinant rat insulin.